Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 875

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 875
---
1 modifications pursuant to ASC 718 because those Stock Awards would have vested before and after the modification. Acceleration of vesting for the Stock Awards that would have vested in the twelve-month period following the consulting term was determined to be a Type 3 modification requiring stock compensation expense pursuant to ASC 718 because absent the modification terms, those Stock Awards would have been forfeited as of the last day that the former CEO provided continuous service as a consultant. In addition, Type 4 performance-based restricted stock units were not considered probable of achieving performance targets on the modification date, but the vesting targets were achieved with respect to 1,444 performance-based restricted stock units in February 2022, which resulted in additional stock compensation expense being recorded through June 30, 2022. During the year ended December 31, 2022, total incremental stock compensation expense relating to modifications of stock options, time-based and performance-based restricted stock units of the former CEO was $2,563, which was included in G&A expense. Of this total amount, $1,679 was included in G&A expense in the stock option expense table above for the year ended December 31, 2022. During the year ended December 31, 2021, total incremental stock compensation expense relating to modifications of stock options and time-based restricted stock units of the former CEO was $5,056, which was included in G&A expense. Of that total amount, $4,908 is included in G&A expense in the stock option compensation expense table above for the year ended December 31, 2021. 16. Income Taxes The Company’s benefit from income taxes is as follows:

| ​                         
 ​                         
 Current:                  | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | December 31, 
 2023         
 ​            | ​ | ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2022 
 ​    | ​ | ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2021 
 ​    | ​ | ​ | ​ | ​ 
 ​ 
 ​ |
|:--------------------------|:--|:--|:-------------|:--|:--|:--|:--|:--|:-----|:--|:--|:--|:--|:--|:-----|:--|:--|:--|:--|
| Federal                   | ​ | ​ | ​            | $ | — | ​ | ​ | ​ | ​    |